The Chemours Company (CC) — Fair Value Analysis
Base-case fair value (P50): $19.27 · Current price: $23.00 · Verdict: Overvalued
The Verdict on CC
CHEMOURS (CC) currently trades at $23.00, which is above our Monte Carlo simulation's median fair value (P50) of $19.27. Despite this, our analysis indicates CC is Fairly Valued. While the current price implies -16.2% against the P50, the broader distribution from our simulations suggests the stock is trading within a reasonable range, rather than being explicitly overvalued. Investors should note this nuanced position where the market price exceeds the median fair value, yet the overall risk/reward profile doesn't warrant an "overvalued" label based on our comprehensive modeling.
How CC stacks up against peers
When evaluating CHEMOURS, its quality tier is assessed as weak in terms of operational and financial health relative to its sector peers. This weak quality standing introduces a layer of caution, even as our Monte Carlo simulations deem CC Fairly Valued. The discrepancy between a current price of $23.00 (above the $19.27 median) and a weak quality tier suggests that while the stock isn't considered significantly overpriced by the model, its underlying fundamentals could present challenges that might cap significant upside potential or increase volatility compared to stronger-performing rivals.
What this means for investors
For investors considering CC at $23.00, the "Fairly Valued" verdict from our Monte Carlo simulations, alongside a weak quality tier, paints a picture of a company trading close to its intrinsic value with some fundamental headwinds. The current trading price above the $19.27 median of $19.27 results in a -16.2% indication, but the extensive scenario modeling supports a "Fairly Valued" assessment. This implies a balanced outlook, where significant undervaluation or overvaluation is not currently present. To explore the full bear and bull distribution and track CC's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is CC overvalued or undervalued right now?
CHEMOURS (CC) is currently assessed as Fairly Valued based on our Monte Carlo simulations, with a current price of $23.00 compared to a median fair value (P50) of $19.27.
What is the bear case and bull case for CC?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside or downside, is available with a free FairCurve account.
How does FairCurve calculate CC's fair value?
FairCurve calculates CC's fair value using Monte Carlo simulations, modeling thousands of forward scenarios to determine a probabilistic distribution of potential intrinsic values.
How can I track CC's fair value as it changes?
Add CC to your free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings reports or significant fundamental data are released.